2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Insurance Revenue | 19,314,000 | 10.277% | 17,514,000 | 16,319,000 | -- | -- |
Interest Income | 7,988,000 | 2.148% | 7,820,000 | 7,267,000 | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | -- | -- | -- | -- | 37,123,000 | 35,780,000 |
Net Premium Income | -- | -- | -- | -- | 34,444,000 | 33,328,000 |
Investment Income/(Loss) | 3,965,000 | -19.753% | 4,941,000 | (38,647,000) | 8,660,000 | 8,159,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | 2,348,000 | 1,386,000 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | 1,161,000 | 7,294,000 |
Other Income/(Loss) | 442,000 | 8.333% | 408,000 | 1,579,000 | 912,000 | 192,000 |
Total Revenues | 31,709,000 | 3.344% | 30,683,000 | (13,482,000) | 47,525,000 | 50,359,000 |
Insurance Service Expenses | (13,136,000) | 8.760% | (12,078,000) | (10,434,000) | -- | -- |
Net Expenses from Reinsurance Contracts | (409,000) | 18.551% | (345,000) | (419,000) | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | (7,612,000) | -27.200% | (10,456,000) | 30,957,000 | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | 105,000 | 61.538% | 65,000 | 67,000 | -- | -- |
Net Impairment Loss | (16,000) | -91.795% | (195,000) | (233,000) | -- | -- |
Other Expenses | (3,161,000) | 11.185% | (2,843,000) | (2,281,000) | (39,046,000) | (43,072,000) |
Other Non-operating Items | 0 | -- | 0 | 0 | -- | -- |
Share of results of Associates & JCEs | 351,000 | -- | (267,000) | (121,000) | (11,000) | (17,000) |
Profit / (Loss) before Taxation | 7,831,000 | 71.582% | 4,564,000 | 4,054,000 | 8,468,000 | 7,270,000 |
Taxation | (978,000) | 24.904% | (783,000) | (689,000) | (991,000) | (1,491,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (17,000) | 0.000% | (17,000) | (34,000) | (50,000) | 0 |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 6,836,000 | 81.615% | 3,764,000 | 3,331,000 | 7,427,000 | 5,779,000 |
2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Depreciation & Amortisation | 473,000 | 13.702% | 416,000 | 391,000 | 407,000 | 407,000 |
Directors' Emoluments | 18,464 | 4.679% | 17,638 | 17,484 | 18,650 | 31,966 |
2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
EPS (cts) | 62.000 | 87.879% | 33.000 | 28.000 | 62.000 | 48.000 |
DPS (cts) | 22.576 | -- | 20.630 | 19.579 | 18.663 | 17.440 |
Dividend Payout Ratio (%) | 36.412% | -- | 62.516% | 69.926% | 30.101% | 36.334% |
Cash flow per share ($) | 0.295 | -- | 0.948 | 0.827 | 0.324 | 0.195 |
NBV per share ($) | 3.738 | -- | 3.606 | 3.792 | 4.999 | 5.225 |
Remarks: | Real time quote last updated: 31/03/2025 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders ($) | USD 6,836,000,000 |
%Change | 81.615% |
EPS / (LPS) | USD 0.620 |
NBV Per Share ($) | USD 3.738 |